See how top analysts and institutions rate TEVA — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Goldman | Initiated | Buy | $24 | 2025-06-06 |
| Truist | Initiated | Buy | $25 | 2025-05-28 |
| JP Morgan | Upgrade | Neutral → Overweight | $23 | 2025-05-12 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 2 | 8 | 1 | 0 | 0 |
| October 2025 | 3 | 8 | 0 | 0 | 0 |
| September 2025 | 3 | 7 | 1 | 0 | 0 |
| August 2025 | 3 | 7 | 1 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for TEVA, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
